Date Filer Title Filing Type Shares Traded Price Total Held
Feb 15, 2024
CHIEF MEDICAL OFFICER
CHIEF MEDICAL OFFICER Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,081 $1.27 31,487
Feb 15, 2024
CHIEF OPERATING OFFICER
CHIEF OPERATING OFFICER Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,229 $1.27 48,644
Aug 23, 2018
Chief Scientific Officer
Chief Scientific Officer Form 4 Conversion of derivative security 1,231 -- 8,585
Aug 23, 2018
Director, President and CEO
Director, President and CEO Form 4 Open market or private purchase of non-derivative or derivative security 1,630 $6.12 1,630
Aug 23, 2018
Director, President and CEO
Director, President and CEO Form 4 Open market or private purchase of non-derivative or derivative security 1,630 -- 1,630
Nov 29, 2021
Director, President and CEO
Director, President and CEO Form 4 Open market or private purchase of non-derivative or derivative security 2,200 $3.98 2,200
Aug 23, 2018
Chief Scientific Officer
Chief Scientific Officer Form 4 Conversion of derivative security 2,433 -- 112,936
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 2,505 $4.59 6,891
Nov 29, 2021
Director, President and CEO
Director, President and CEO Form 4 Open market or private purchase of non-derivative or derivative security 2,675 $3.99 4,875
Feb 15, 2024
Director, PRESIDENT AND CEO
Director, PRESIDENT AND CEO Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 3,073 $1.27 77,663

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.